Some cholinergic themes related to Alzheimer's disease: Synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity

Journal of Physiology Paris

Volumn 92, Issue 3-4, 1998, Pages 293-298

  Mesulam, M Marsel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AUTORECEPTOR; CHOLINE ACETYLTRANSFERASE; MUSCARINIC M2 RECEPTOR; NITRIC OXIDE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN CORTEX; CHOLINERGIC SYSTEM; CONFERENCE PAPER; GABAERGIC SYSTEM; MONKEY; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROTOXICITY; NONHUMAN; OLIVARY NUCLEUS; RAT; SYNAPSE;

EID: 0032105401     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80036-3     Document Type: Conference Paper

References (56)

1. [1] Arendash G.W., Millard W.J., Dunn A.J., Meyer E.M., Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat, Science 238 (1987) 952-956.
2. [2] Auld D.S., Kar S., Quirion R., β-Amyloid peptides as direct cholinergic neuromodulators:a missing link?, Trends Neurosci. 21 (1998) 43-49.
3. [3] Baskerville K.A., Schweitzer J.B., Herron P., Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat, Neuroscience 80 (1997) 1159-1169.
4. [4] Bear M.F., Singer W., Modulation of visual cortical plasticity by acetylcholine and noradrenaline, Nature 320 (1986) 172-176.
5. [5] Black J.E., Polinsky M., Greenough W.T., Progressive failure of cerebral agiogenesis supporting neural plasticity in aging rats, Neurobiol. Age 10 (1989) 353-358.
6. [6] Bonner T.I., Buckley N.J., Young A.C., Brann M.R., Identification of a family of muscarinic acetylcholine receptor genes, Science 237 (1987) 527-532.
7. [7] Bonner T.I., Young A.C., Brann M.R., Buckley N.J., Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes, Neuron 1 (1988) 403-410.
8. [8] Buckley N.J., Bonner T.I., Brann M.R., Localization of muscarinic receptor mRNAs in rat brain, J. Neurosci. 8 (1988) 4646-4652.
9. [9] Cohen M.L., Golde T.E., Usiak M.F., Younkin L.H., Younkin S.G., In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer's disease, Proc. Natl. Acad. Sci. USA 85 (1988) 1227-1231.
10. [10] Cotman C.W., Nieto-Sampedro M., Cell biology of synaptic plasticity, Science 225 (1984) 1287-1294.
11. [11] Dringenberg H.C., Vanderwolf C.H., Neocortical activation: modulation by multiple pathways acting on central cholinergic and serotonergic systems, Exp. Brain Res. 116 (1997) 160-174.
12. [12] Emre M., Geula C., Ransil B.J., Mesulam M.M., The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain, Neurobiol. Aging 13 (1992) 553-559.
13. [13] Farkas R.H., Nakajima S., Nakajima Y., Neurotensin excites basal forebrain cholinergic neurons: ionic and signal-transduction mechanisms, Proc. Natl. Acad. Sci. USA 91 (1994) 2853-2857.
14. [14] Freund T.F., Meskenaite V., γ-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex, Proc. Natl. Acad. Sci. USA 89 (1992) 738-742.
15. [15] Gaspar P., Berger B., Alvarez C., Vigny A., Henry J.P., Catecholaminergic innervation of the septal area in man: immunocytochemical study using TH and DBH antibodies, J. Comp. Neurol. 241 (1985) 12-33.
16. [16] Gaykema R.P., Záborzsky L., Direct catecholaminergic-cholinergic interactions in the basal forebrain. II Substantia nigra-ventral tegmental area projections to cholinergic neurons, J. Comp. Neural. 374 (1996) 555-577.
17. [17] Geula C., Mesulam M.-M.: Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease, in: Terry R.D., Katzman R. and Bick K.L. (Eds.), Alzheimer Disease, Raven Press, New York, 1994, pp. 263-294.
18. [18] Gritti I., Mainville L., Jones B.E., Codistribution of GABA with acetylcholine-synthesizing neurons in the basal forebrain of the rat, J. Comp. Neurol. 329 (1993) 438-457.
19. [19] Harata N., Tateishi N., Akaike N., Acetylcholine receptors in dissociated nucleus basalis of Meynert neurons of the rat, Neurosci. Lett. 130 (1991) 153-156.
20. [20] Ingham C.A., Bolam J.P., Wainer B.H., Smith A.D., A correlated light and electron microscopic study of identified cholinergic basal forebrain neurons that project to the cortex in the rat, J. Comp. Neurol. 239 (1985) 176-192.
21. [21] Jones B., Cuello A.C., afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin and acetylcholine-neurons, Neuroscience 31 (1989) 37-61.
22. [22] Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., Mattson M.P., Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons, Proc. Natl. Acad. Sci. USA 93 (1996) 6753-6758.
23. [23] Kihara T., Shimohama S., Sawaa H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A., Nicotinic receptor stimulation protects neurons against β-amyloid toxicity, Ann. Neurol. 42 (1997) 159-163.
24. [24] Kilgard M.P., Merzenich M.M., Cortical map reorganization enabled by nucleus basalis activity, Science 279 (1998) 1714-1718.
25. [25] Kowall N.W., Beal M.F., Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in Alzheimer's disease, Ann. Neurol. 23 (1988) 105-114.
26. [26] Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S., Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor, Nature 323 (1986) 411-416.
27. [27] Levey A.I., Edmunds S.M., Heilman C.J., Desmond T.J., Frey K.A., Localization of muscarinic m3 receptor protein and M3 receptor binding in the rat brain. Neuroscience 63 (1994) 207-221.
28. [28] Levey A.I., Edmunds S.M., Hersch S.M., Wiley R.G., Heilman C.J., Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat, J. Comp. Neurol. 351 (1995) 339-356.
29. [29] Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R., Identification and localization of muscarinic acetylcholine receptor protein in brain with subtype-specific antibodies, J. Neurosci. 11 (1991) 3218-3226.
30. [30] Martinez-Murillo R., Villalba R.M., Rodrigo J., Immunocytochemical localization of cholinergic terminals in the region of the nucleus basalis magnocellularis of the rat: A correlated light and electron microscopic study, Neuroscience 36 (1990) 361-376.
31. [31] Mash D.C., Flynn D.D., Potter L.T., Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation, Science 228 (1985) 115-117.
32. [32] Mash D.C., White W.F., Mesulam M.M., Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex, J. Comp. Neurol. 278 (1988) 265-274.
33. [33] Mesulam M.-M., Asymmetry of neural feedback in the organization of behavioral states, Science 237 (1987) 537-538.
34. [34] Mesulam M.-M., Large-scale neurocognitive networks and distributed processing for attention, language, and memory, Ann. Neurol. 28 (1990) 597-613.
35. [35] Mesulam M.-M., Mufson E.J., Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey, Brain 107 (1984) 253-274.
36. [36] Mrzljak L., Levey A.I., Belcher S., Goldman-Rakic P.S., Localiation of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey, J. Comp. Neurol. 390 (1998) 112-132.
37. [37] Mrzljak L., Levey A.I., Goldman-Rakic P.S., Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: Morphological evidence for cholinergic modulation of excitatory neurotransmission, Proc. Natl. Acad. Sci. USA 90 (1993) 5194-5198.
38. [38] Mufson E.J., Jaffar S., Levey A.I., m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya, J. Comp. Neurol. 392 (1998) 313-329.
39. [39] Nakajima Y., Nakajima S., Obata K., Carlson C.G., Yamaguchi K., Dissociated cell culture of cholinergic neurons from nucleus basalis of Meynert and other basal forebrain nuclei, Proc. Natl. Acad. Sci. USA 82 (1985) 6325-6329.
40. [40] Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H., Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors, Science 258 (1992) 304-307.
41. [41] Owen A., Bird M., Acetylcholine as a regulator of neurite outgrowth and motility in cultured embryonic mouse spinal cord, NeuroReport 6 (1995) 2269-2272.
42. [42] Palacios G., The endomembrane system of cholinergic and non-cholinergic neurons in the medial septal nucleus and vertical limb of the diagonal band of Broca: A cytochemical and immunocytochemical study, J. Histochem. Cytochem. 38 (1990) 563-571.
43. [43] Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J., Capon D.J., Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors, EMBO J. 6 (1987) 3923-3929.
44. [44] Smiley J.F., Levey A.I., Mesulam M.-M., m2 muscarinic receptor immunolocalization in cholinergic cells of the monkey basal forebrain, Soc. Neurosci. Abstr. 23 (1997) 2021.
45. [45] Smiley J.F., Levey A.I., Mesulam M.-M., Infracortical interstitial cells concurrently expressing m2-muscarinic receptors, AChE, and NADPH-d in the human and monkey cerebral cortex, Neuroscience 84 (1998) 755-769.
46. [46] Smiley J.F., Mesulam M.-M., Dopamine, norepinephrine, and serotonin axons in the human and monkey nucleus basalis and in Alzheimer's disease, Soc. Neurosci. Abstr. 21 (1995) 1621.
47. [47] Smiley J.F., Mesulam M.-M., Cholinergic neurons of the nucleus basalis of Meynert (Ch4) receive cholinergic, catecholaminergic, and GABAergic synapses: an electron microscopic investigation in the monkey, Neuroscience (1998), in press.
48. [48] Svensson A.L., Warpman U., Hellstrom-Lindahl E., Bogdanovic N., Lannfelt L., Nordberg A., Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes, Neurosci. Lett. 232 (1997) 37-40.
49. [49] Tellez S., Colpaert F., Marien M., The a2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo. Eur. J. Pharmacol. 277 (1995) 113-116.
50. [50] Vilaró M.T., Wiederhold K.-H., Palacios J.M., Mengod G., Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography, Neuroscience 47 (1992) 367-393.
51. [51] Walker L.C., Tigges M., Tigges J., Ultrastructure of neurons in the nucleus basalis of Meynert in squirrel monkey, J. Comp. Neurol. 217 (1983) 158-166.
52. [52] Záborsky L., Gaykema R.P., Swanson D.J., Cullinan W.E., Cortical input to the basal forebrain, Neuroscience 79 (1997) 1051-1078.
53. [53] Záborszky L., Cullinan W.E., Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-β-hydroxylase-and tyrosine hydroxylase input to cholinergic neurons, J. Comp. Neurol. 374 (1996) 535-554.
54. [54] Záborszky L., Leranth C., Heimer L., Ultrastructural evidence of amygdalofugal axons terminating on cholinergic cells of the rostral forebrain, Neurosci. Lett. 52 (1984) 219-225.
55. [55] Zhu X.O., Waite P.M.E., Cholinergic depletion reduces plasticity of barrel field cortex, Cereb. Cortex 8 (1998) 63-72.
56. [56] Zilles K., Werner L., Qü M., Schleicher A., Gross G., Quantitative autoradiography of 11 different transmitter binding sites in the basal forebrain region of the rat-evidence of heterogeneity in distribution patterns, Neuroscience 42 (1991) 473-481.